ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,331Top JournalReview JournalHybrid

Seminars in Oncology

Acronym:ysonc
•
Abbreviation (ISO):SEMIN ONCOL
•
Identifier (ISSN):0093-7754(Print)/1532-8708(Online)
•
Publisher:W.B. Saunders Ltd
Clarivate IF (2026)
6.8↑ +4.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Seminars in Oncology

WoS Q1
14694.9420183.6120194.2120204.9320215.38202242023320242.520256.82026
Annual Impact Factor Metric
Current (2026):6.8
Scopus SJR & RankScopus Q1
1.536
#2,331

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
153

153 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
33articles/year
19.47% Gold OA•0% Original Research

Aims & Scope

Seminars in Oncology brings you current, authoritative, and practical reviews of developments in the etiology, diagnosis and management of cancer. Each issue examines topics of clinical importance, with an emphasis on providing both the basic knowledge needed to better understand a topic as well as evidence-based opinions from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing a diversity of opinions including those that might be considered "outside the box". We welcome a healthy and respectful exchange of opinions and urge you to approach us with your insights as well as suggestions of topics that you deem worthy of coverage. By helping the reader understand the basic biology and the therapy of cancer as they learn the nuances from experts, all in a journal that encourages the exchange of ideas we aim to help move the treatment of cancer forward.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsOncology & Cancer ResearchSurgeryOncologyPathologyChemistryImmunologyBiochemistryCancer Research
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank57/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank219/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.8
Articles / Year62
Total Citations16
2025
IF2.5
Articles / Year96
Total Citations383
2024
IF3
Articles / Year31
Total Citations132
2023
IF4
Articles / Year38
Total Citations435
2022
IF5.385
Articles / Year78
Total Citations601

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,331Scopus Q1SCImago Profile
Scopus Coverage:1974-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.536

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.88

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,502 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations416
3-Year Documents102
Citable Documents97

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Seminars in Oncology (acronym: ysonc, abbr: SEMIN ONCOL, ISSN: 0093-7754) is a peer-reviewed international scholarly journal in the field of Medicine, published by W.B. Saunders Ltd in United States since 1974. The periodical holds a Journal Impact Factor (JIF) of 6.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.536 (Q1), an H-index of 153.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 33 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,502 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
W.B. Saunders Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
1974
Indexing & Databases
SCIEScopusPubMed
Editorial Address
W B SAUNDERS CO-ELSEVIER INC, 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, USA, PA, 19103-2899

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4f862d90-ad7a-4e13-993d-6942c029190c
Database Updated: 2026-10-16